scholarly journals A short N-terminal domain of HDAC4 preserves photoreceptors and restores visual function in retinitis pigmentosa

2015 ◽  
Vol 6 (1) ◽  
Author(s):  
Xinzheng Guo ◽  
Shao-Bin Wang ◽  
Hongping Xu ◽  
Adema Ribic ◽  
Ethan J. Mohns ◽  
...  
Keyword(s):  
Retinitis Pigmentosa ◽  
Visual Function ◽  
Terminal Domain

scholarly journals An Instrument Capable of Grading Visual Function: Results from Patients with Retinitis Pigmentosa

2004 ◽  
Vol 203 (4) ◽  
pp. 305-312 ◽  
Author(s):  
Makoto Tamai ◽  
Hiroshi Kunikata ◽  
Toshitaka Itabashi ◽  
Miyuki Kawamura ◽  
Yoko Saigo ◽  
...  
Keyword(s):  
Retinitis Pigmentosa ◽  
Visual Function

scholarly journals Safety, effectiveness, and cost-effectiveness of Argus II in patients with retinitis pigmentosa: a systematic review

2021 ◽  
Vol 14 (2) ◽  
pp. 310-316
Author(s):  
Zakieh Ostad-Ahmadi ◽  
◽  
Mohammad-Reza Modabberi ◽  
Ali Mostafaie ◽  
◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Retinitis Pigmentosa ◽  
Visual Function ◽  
Cost Effective ◽  
Quality Adjusted Life Year ◽  
Bionic Eye ◽  
Argus Ii ◽  
Safety Effectiveness ◽  
The Cost ◽  
Effectiveness Studies

AIM: To assess the effectiveness, safety, and cost-effectiveness of the Argus II in treatment of the retinitis pigmentosa (RP) patients. METHODS: The ProQuest, Web of Science, EMBASE, MEDLINE (via PubMed) were searched using combinations of the keywords of Argus, safety, effectiveness, bionic eye, retinal prosthesis, and RP through March 2018. The retrieved records were screened and then assessed for eligibility. RESULTS: Totally 926 records were retrieved from the searched databases and finally 12 studies included. The RP patients showed improvements in visual function after receiving the prosthesis, compared to the time before the prosthesis or the time it was off. This was measured by square localization, direction of motion, and grating visual acuity tests. No major adverse effect was reported for the Argus II prosthesis itself and/or the surgery to implement it, but the most frequently reported items were hypotony, and conjunctival dehiscence. The incremental cost-effectiveness ratio (ICER) was calculated to be €14603 per quality-adjusted life year (QALY) in UK and $207 616 per QALY in Canada. CONCLUSION: The available evidence shows that the Argus II prosthesis in RP patients is effective in improvement of their visual function. Some minor adverse effects are reported for the prosthesis. The cost-effectiveness studies show that the technology is cost-effective only at high levels of willingness-to-pay.

Visual function changes in an animal model of retinitis pigmentosa

2013 ◽  
Vol 91 ◽  
pp. 0-0
Author(s):  
F SEGURA CALVO ◽  
C LÓPEZ DE LA FUENTE ◽  
A SÁNCHEZ-CANO ◽  
L FUENTES-BROTO ◽  
D PÉREZ-GARCÍA ◽  
...  
Keyword(s):  
Animal Model ◽  
Retinitis Pigmentosa ◽  
Visual Function

Interocular asymmetry of visual function in heterozygotes of X-linked retinitis pigmentosa

1989 ◽  
Vol 48 (5) ◽  
pp. 679-691 ◽  
Author(s):  
Samuel G. Jacobson ◽  
Katsuya Yagasaki ◽  
William J. Feuer ◽  
Alejandro J. Román
Keyword(s):  
Retinitis Pigmentosa ◽  
Visual Function

scholarly journals Environmental Enrichment Extends Photoreceptor Survival and Visual Function in a Mouse Model of Retinitis Pigmentosa

PLoS ONE ◽  
2012 ◽  
Vol 7 (11) ◽  
pp. e50726 ◽  
Author(s):  
Ilaria Barone ◽  
Elena Novelli ◽  
Ilaria Piano ◽  
Claudia Gargini ◽  
Enrica Strettoi
Keyword(s):  
Mouse Model ◽  
Retinitis Pigmentosa ◽  
Visual Function ◽  
Environmental Enrichment

scholarly journals Transplantation of Reprogrammed Embryonic Stem Cells Improves Visual Function in a Mouse Model for Retinitis Pigmentosa

2010 ◽  
Vol 89 (8) ◽  
pp. 911-919 ◽  
Author(s):  
Nan-Kai Wang ◽  
Joaquin Tosi ◽  
Jennifer Mie Kasanuki ◽  
Chai Lin Chou ◽  
Jian Kong ◽  
...  
Keyword(s):  
Stem Cells ◽  
Embryonic Stem Cells ◽  
Mouse Model ◽  
Retinitis Pigmentosa ◽  
Visual Function ◽  
Embryonic Stem

scholarly journals Randomized controlled trial of electro-stimulation therapies to modulate retinal blood flow and visual function in retinitis pigmentosa

2017 ◽  
Vol 96 (3) ◽  
pp. e366-e376 ◽  
Author(s):  
Ava K. Bittner ◽  
Kenneth Seger ◽  
Rachel Salveson ◽  
Samantha Kayser ◽  
Natalia Morrison ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Blood Flow ◽  
Retinitis Pigmentosa ◽  
Visual Function ◽  
Controlled Trial ◽  
Retinal Blood Flow ◽  
Randomized Controlled
Sign in / Sign up

Export Citation Format

Share Document